GLP-1 is both influenced by and exerts effects on variables like the microbiome, eating behaviour, glucose tolerance, metabolic profile, medication, sex and weight
Initiation rates for AOM GLP-1 RA are about the same in June 2025, relative to March 2025 (-1.3%)
Side effects like nausea, vomiting, diarrhea, or constipation are common early on but often improve with proper management
Author: Ashley Aguillard Editor: Michaela Price This article will cover a well-known class of drugs for type 2 diabetes (T2D), GLP-1 receptor agonists
A welcome package usually sets the tone, with reloads and cashback rotating throughout the week
The FDA Adverse Event Reporting System shows a likely link between GLP-1 RAs (specifically liraglutide) and increased risk of pancreatitis